Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Shahin Kauser"'
Autor:
Marie-Christine Bielsky, Shahin Kauser, David Brown, Andrew Exley, Leonard Both, Andrea Wallington, Justin L. Hay, Anne Cook
Publikováno v:
Drug Discovery Today. 25:1910-1918
Licensing of biosimilars is essential to promote patient access to 21st-century biological medicines. Regulatory approval of biosimilars is based on the totality of evidence from a head-to-head comparison with reference products (RPs). A clinical eff
Autor:
Shahin, Kauser Ara1 drshahinkauser@gmail.com, Chatra, Laxmikanth2, Shenai, Prashanth1, Rao, Prasanna Kumar1
Publikováno v:
Archives Medical Review Journal / Arsiv Kaynak Tarama Dergisi. 2014, Vol. 23 Issue 2, p197-209. 13p.
Publikováno v:
North American Journal of Medical Sciences. Nov2012, Vol. 4 Issue 11, p586-589. 4p. 4 Charts.
Publikováno v:
Pharmacoepidemiology and Drug Safety. 19:232-237
Purpose The responsibility for monitoring the safety of marketed medicines is shared between regulatory authorities and the pharmaceutical industry and is underpinned by legal obligations on both sides. Both marketing authorisation holders (MAHs) and
Publikováno v:
Pharmacoepidemiology and drug safety. 19(3)
The responsibility for monitoring the safety of marketed medicines is shared between regulatory authorities and the pharmaceutical industry and is underpinned by legal obligations on both sides. Both marketing authorisation holders (MAHs) and regulat
Autor:
Aparna, M., Shenai, Prashanth, Chatra, Laxmikanth, Veena, K. M., Rao, Prasanna Kumar, Prabhu, Rachana V., Shahin, Kauser Ara
Publikováno v:
Archives Medical Review Journal / Arsiv Kaynak Tarama Dergisi; 2014, Vol. 23 Issue 2, p294-302, 9p
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.